With trial results in infants, Merck advances next-gen pneumococcal shot Vaxneuvance in race against Pfizer
TrustVaccines
via FiercePharma: Vaccines https://ift.tt/2zKtXvv
August 25, 2021 at 10:29AM
With trial results in infants, Merck advances next-gen pneumococcal shot Vaxneuvance in race against Pfizer
Welcome to vaccine education 